These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1847506)

  • 1. Hepatitis C. A new virus for an old disease.
    Fitz JG
    N C Med J; 1991 Jan; 52(1):4-6, 8. PubMed ID: 1847506
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis.
    Tsutsumi M; Urashima S; Takada A; Date T; Tanaka Y
    Hepatology; 1994 Feb; 19(2):265-72. PubMed ID: 7507461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C; a new virus for an old disease].
    Reesink HW; van der Poel CL; Chamuleau RA
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2560-4. PubMed ID: 1336130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?
    Wiesner RH
    Hepatology; 2008 Dec; 48(6):1734-6. PubMed ID: 19026008
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
    Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
    Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathology of viral hepatitis C].
    Chevallier M; Degott C
    Pathol Biol (Paris); 1995 Oct; 43(8):703-8. PubMed ID: 8745592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
    Chevaliez S; Pawlotsky JM
    Clin Liver Dis; 2005 Aug; 9(3):371-82, v. PubMed ID: 16023971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
    Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
    J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.
    Kato N; Yokosuka O; Hosoda K; Ito Y; Ohto M; Omata M
    Hepatology; 1993 Jul; 18(1):16-20. PubMed ID: 8392026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
    Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C virus in chronic hepatitis and liver cirrhosis].
    Yamada G; Endo H; Takahashi M; Tsuji T
    Nihon Rinsho; 1991 Feb; 49(2):426-31. PubMed ID: 1849204
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.
    Perlemuter G; Cacoub P; Sbaï A; Hausfater P; Thibault V; Le TH; Wechsler B; Buffet C; Piette JC
    J Rheumatol; 2003 Jul; 30(7):1473-8. PubMed ID: 12858443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
    Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver cirrhosis and membranoproliferative glomerulonephritis caused by inapparent hepatitis C virus infection.
    Kalinski T; Klante T; Päge I; Schneider-Stock R; Dombrowski F; Roessner A
    Pathol Res Pract; 2006; 202(12):891-4. PubMed ID: 17092658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of hepatitis C: patients with cirrhosis.
    Schalm SW; Fattovich G; Brouwer JT
    Hepatology; 1997 Sep; 26(3 Suppl 1):128S-132S. PubMed ID: 9305677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of porphyria cutanea tarda and hepatitis C virus].
    Martín-Vivaldi Martínez R; Espinosa Aguilar MD; Sánchez Sanchéz-Vizcaíno J; Quintero Fuentes D; Nogueras López F; López de Hierro Ruiz M
    Rev Esp Enferm Dig; 1996 Mar; 88(3):213-6. PubMed ID: 8645516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report.
    Kita Y; Beck Y; Teraoka S; Yokota K; Andoh Y; Nagao T; Gotoh M; Sakon M; Monden M
    Transplant Proc; 1996 Jun; 28(3):1701-3. PubMed ID: 8658847
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus (HCV) occult infection or occult HCV RNA detection?
    Lerat H; Hollinger FB
    J Infect Dis; 2004 Jan; 189(1):3-6. PubMed ID: 14702146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.